Given the intrinsic phenotypic plasticity of glioma cells, we sought to determine whether the STAT3 signaling axis could be a potential compensatory mechanism that is adopted by surviving HDAC1-deficient hGSCs. The gene discussed is HDAC1; the disease is central nervous system cancer.